Keynote by Dr. Paul Schmiedmayer and Dr. Oliver Aalami on Stanford Biodesign Digital Health – Scaling Access to Care, 9 Dec 2024
Monday, 9 December 2024, 6.00 pm CET, ZOOM
About Dr. Paul Schmiedmayer & Dr. Oliver Aalami
Dr. Paul Schmiedmayer
Dr. Schmiedmayer is the Lead Artificial Intelligence and Assistant Director of Digital Health at the Stanford Mussallem Center for Biodesign and a postdoctoral researcher at Stanford University. As a researcher at the intersection of AI, medicine, and software engineering, his work explores novel approaches to developing scalable, patient-centered platforms that harness AI and connected devices to deliver real-time, personalized health insights. His research addresses a critical gap by creating and investigating methodologies in healthcare software engineering, focusing on scalable platforms that enhance patient access to healthcare.
Dr. Schmiedmayer’s research addresses these challenges by developing scalable, intelligent, data-driven systems that leverage patient data and connected devices to provide real-time, personalized healthcare. He aims to validate these solutions by deploying AI-based models on resource-constrained, patient-facing devices, such as smartphones and smart devices, ensuring that personalized medicine is both cost-effective and privacy-preserving. The research’s long-term goal is to create closed-loop systems that seamlessly integrate cutting-edge AI research with clinical practice, leveraging software and hardware integrations to identify novel digital biomarkers and making healthcare personalized, scalable, equitable, and accessible to all.
Dr. Oliver Aalami
Dr. Oliver Aalami is a Clinical Associate Professor of Vascular & Endovascular Surgery at Stanford University and the Palo Alto VA, where he integrates clinical expertise with pioneering digital health initiatives. As the Director of Stanford Biodesign’s Digital Health unit, Dr. Aalami plays a key role in advancing the development of sensor-based technologies aimed at transforming cardiovascular care. He serves as the course director for “Biodesign for Digital Health” and “Building for Digital Health,” guiding students and innovators through the intricacies of creating and implementing digital solutions for health. Under Dr. Aalami’s leadership, Stanford launched Spezi, an open-source framework designed to accelerate mobile health research. Spezi is specifically tailored to support sensor-based projects by providing a customizable infrastructure for mobile studies, enabling a broader and more efficient approach to collecting real-world health data. Through supporting projects, he aims to enhance the precision of health monitoring for patients, paving the way for more individualized and data-driven care.
About the Lecture
The Stanford Mussallem Center for Biodesign’s Digital Health group aims to scale access to care by integrating cutting-edge AI, connected devices, and data-driven solutions. To accelerate research and translational efforts in digital health and AI, the group has developed Stanford Spezi, an open-source framework leveraging HL7 FHIR standards to enable modular, interoperable healthcare applications. Spezi has flourished through project-based use and open-source contributions, fostering an international development community and now supporting over 20 digital health and AI projects at Stanford and beyond.
The group’s research portfolio and collaborations includes patient and provider-facing solutions. This includes initiatives such as LLMonFHIR, addressing patient health literacy; ENGAGE-HF, supporting guideline-based therapy for heart failure; HrtEx, streamlining hypertension medication management; and Quantitative DigitoGraphy, advancing care for individuals with Parkinson’s disease. These projects exemplify how interdisciplinary collaborations can address unmet clinical needs and drive innovation in healthcare.
In addition to its research and translational work, the group educates the next generation of digital health innovators through Stanford courses such as BIOE 273: Biodesign for Digital Health and CS342: Building for Digital Health. These programs equip students with the skills to explore and translate digital health opportunities with every stakeholder in mind.
We are pleased to invite you to join this guest lecture, which is part of our CDHI Lecture Series Digital Health Forum. Registration is not required. Please be aware that we will be recording this guest lecture and will be making it available in our teaching library. If you have any questions, please contact Victoria Brügger (victoria.bruegger@unisg.ch) prior to the start of the guest lecture.
Prof. Dr. Tobias Kowatsch, Associate Professor for Digital Health Interventions, Institute for Implementation Science in Health Care, University of Zurich; Director, School of Medicine, University of St.Gallen (HSG); Scientific Director, Centre for Digital Health Interventions (CDHI), ETH Zurich & HSG; Principal Investigator, Future Health Technologies programme, Campus for Research Excellence and Technological Enterprise (CREATE), Singapore-ETH Centre, Singapore
Prof. Dr. Elgar Fleisch, Professor of Information Management, ETH Zürich; Professor of Technology Management, University of St.Gallen; Advisory Board Member, CDHI, ETH Zürich & University of St.Gallen; Principal Investigator, Future Health Technologies programme, Campus for Research Excellence and Technological Enterprise (CREATE), Singapore-ETH Centre, Singapore
Prof. Dr. Florian von Wangenheim, Professor of Technology Marketing, ETH Zurich & Advisory Board Member, CDHI; Principal Investigator, Future Health Technologies programme, Campus for Research Excellence and Technological Enterprise (CREATE), Singapore-ETH Centre, Singapore
